DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Unknown
Unknown
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADALIMUMAB-AFZB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ADALIMUMAB-AFZB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHYL NITRITE [SPIRIT]
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ETHYL NITRITE [SPIRIT]
×
Maximum Phase:
4
First Approval:
None
UNII:
8C7CJ279RV
Molecule Type:
Small molecule
Molecular Formula:
C2H5NO2
Molecular Weight:
75.07
AlogP:
0.7
PSA:
38.66
HBD:
0.0
HBA:
#RotB:
2.0
Source:
MERBROMIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MERBROMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
M0T18YH28D
Molecule Type:
Small molecule
Molecular Formula:
C20H8Br2HgNa2O6
Molecular Weight:
750.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CITRIC ACID; UREA C-13
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CITRIC ACID; UREA C-13
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMOXICILLIN; CLAVULANATE POTASSIUM
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMOXICILLIN; CLAVULANATE POTASSIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NATRECOR
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
NATRECOR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOCETAMIC ACID
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
IOCETAMIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
FA675Q0E3E
Molecule Type:
Small molecule
Molecular Formula:
C12H13I3N2O3
Molecular Weight:
613.96
AlogP:
3.16
PSA:
83.63
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENOXYPROPAZINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Monoamine oxidase inhibitor
PHENOXYPROPAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8E92V52324
Molecule Type:
Small molecule
Molecular Formula:
C9H14N2O
Molecular Weight:
166.22
AlogP:
0.92
PSA:
47.28
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TASONERMIN
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
TASONERMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
23CA79S88F
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXAMETHASONE; TOBRAMYCIN
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
DEXAMETHASONE; TOBRAMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHOPHOLINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METHOPHOLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
72L4ZT2W1P
Molecule Type:
Small molecule
Molecular Formula:
C20H24ClNO2
Molecular Weight:
345.87
AlogP:
4.52
PSA:
21.7
HBD:
0.0
HBA:
#RotB:
5.0
Source:
FREMANEZUMAB-VFRM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FREMANEZUMAB-VFRM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTHIEPIN
4
Small molecule
Unknown
Unknown
Unknown
Depressive Disorder
Norepinephrine transporter inhibitor
DOTHIEPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
W13O82Z7HL
Molecule Type:
Small molecule
Molecular Formula:
C19H21NS
Molecular Weight:
295.45
AlogP:
4.68
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
3.0
Source:
CLOMETACIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Cyclooxygenase inhibitor
CLOMETACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
L9M34YK25C
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClNO4
Molecular Weight:
357.79
AlogP:
3.93
PSA:
68.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CEFPIROME SULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CEFPIROME SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
BA5ALU2ZT9
Molecule Type:
Small molecule
Molecular Formula:
C22H24N6O9S3
Molecular Weight:
612.67
AlogP:
-1.04
PSA:
153.92
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
4
Combination
Approved
OTHER
N/A
Unknown
Unknown
CYANOCOBALAMIN; CYANOCOBALAMIN CO-57; CYANOCOBALAMIN CO-58
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINOSALICYLIC ACID RESIN COMPLEX
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
AMINOSALICYLIC ACID RESIN COMPLEX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
4
Combination
Approved
OTHER
IRRIGATION
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; OXIGLUTATIONE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOXIPRIN
4
Unknown
Approved
Unknown
Unknown
Fever; Pain; Thrombosis
Cyclooxygenase inhibitor
ALOXIPRIN
×
Maximum Phase:
4
First Approval:
None
UNII:
6QT214X4XU
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENBUFEN
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Unknown
FENBUFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
9815R1WR9B
Molecule Type:
Small molecule
Molecular Formula:
C16H14O3
Molecular Weight:
254.28
AlogP:
3.4
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DEXTROMORAMIDE
4
Small molecule
Approved
Unknown
Unknown
Pain
Opioid receptors; mu/kappa/delta agonist
DEXTROMORAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
9S4S6CIY83
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O2
Molecular Weight:
392.54
AlogP:
3.71
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
6.0
Source:
TALAMPICILLIN HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TALAMPICILLIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
4C5O3X072I
Molecule Type:
Small molecule
Molecular Formula:
C24H24ClN3O6S
Molecular Weight:
517.99
AlogP:
1.65
PSA:
128.03
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SULFAMETHOXYPYRIDAZINE
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial dihydropteroate synthase inhibitor
SULFAMETHOXYPYRIDAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
T034E4NS2Z
Molecule Type:
Small molecule
Molecular Formula:
C11H12N4O3S
Molecular Weight:
280.31
AlogP:
0.87
PSA:
107.2
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TYROTHRICIN
4
Protein
Approved
Unknown
Unknown
Eye Infections
Unknown
TYROTHRICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
877376V2XW
Molecule Type:
Protein
Molecular Formula:
C65H85N11O13
Molecular Weight:
1228.46
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DICOBALT EDETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Cyanide sequestering agent
DICOBALT EDETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
UKC6GH80QR
Molecule Type:
Small molecule
Molecular Formula:
C10H12Co2N2O8
Molecular Weight:
406.08
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
OMEGA-3ACID ETHYL ESTERS
4
Unknown
Approved
OTHER
ORAL
Unknown
Unknown
OMEGA-3ACID ETHYL ESTERS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
Botulinum Toxin Type B
4
Unknown
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM
UNKNOWN
Unknown
Vesicle-associated membrane protein 2 inhibitor
Botulinum Toxin Type B
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMOCILLIN
4
Small molecule
Approved
Unknown
Unknown
Bacteremia; Bacterial Infections; Urinary Tract Infections
Bacterial penicillin-binding protein inhibitor
TEMOCILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
03QB156W6I
Molecule Type:
Small molecule
Molecular Formula:
C16H18N2O7S2
Molecular Weight:
414.46
AlogP:
0.52
PSA:
133.24
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TOFOGLIFLOZIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
TOFOGLIFLOZIN
×
Maximum Phase:
4
First Approval:
None
UNII:
554245W62T
Molecule Type:
Small molecule
Molecular Formula:
C22H26O6
Molecular Weight:
386.44
AlogP:
1.0
PSA:
99.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; CARISOPRODOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; CARISOPRODOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISATUXIMAB-IRFC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ISATUXIMAB-IRFC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
299
300
301
302
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA